0000899243-21-028879.txt : 20210719 0000899243-21-028879.hdr.sgml : 20210719 20210719201601 ACCESSION NUMBER: 0000899243-21-028879 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210719 FILED AS OF DATE: 20210719 DATE AS OF CHANGE: 20210719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Encrantz Staffan CENTRAL INDEX KEY: 0001870875 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40587 FILM NUMBER: 211099149 MAIL ADDRESS: STREET 1: C/O SIGHT SCIENCES, INC. STREET 2: 4040 CAMPBELL AVENUE, SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sight Sciences, Inc. CENTRAL INDEX KEY: 0001531177 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 800625749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 3, SUITE 105 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: (415) 889-0550 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 3, SUITE 105 CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-07-19 0 0001531177 Sight Sciences, Inc. SGHT 0001870875 Encrantz Staffan C/O SIGHT SCIENCES, INC. 4040 CAMPBELL AVE, SUITE 100 MENLO PARK CA 94025 1 0 0 0 Common Stock 2021-07-19 4 C 0 2970070 0.00 A 2970070 I See footnote Common Stock 2021-07-19 4 C 0 632456 0.00 A 632456 I See footnote Series A Redeemable Convertible Preferred Stock 2021-07-19 4 C 0 724637 0.00 D Common Stock 1449274 0 I See footnote Series B Redeemable Convertible Preferred Stock 2021-07-19 4 C 0 98745 0.00 D Common Stock 197490 0 I See footnote Series C Redeemable Convertible Preferred Stock 2021-07-19 4 C 0 661653 0.00 D Common Stock 1323306 0 I See footnote Series C Redeemable Convertible Preferred Stock 2021-07-19 4 C 0 316228 0.00 D Common Stock 632456 0 I See footnote These shares are held of record by Allegro Investment Fund, L.P. ("Allegro Investment Fund"). The Reporting Person is the President of Allegro Investment Inc., the investment manager of Allegro Investment Fund, and may be deemed to beneficially own the shares held by Allegro Investment Fund. The Reporting Person disclaims beneficial ownership of the shares held by Allegro Investment Fund (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any. These shares are held of record by Allegro Investors LLC ("Allegro Investors"). The Reporting Person is a member of Allegro Investors and may be deemed to beneficially own the shares held by Allegro Investors. This series of preferred stock has no expiration date and automatically converted into common stock on a 2 for 1 basis upon the closing of the Issuer's initial public offering. /s/ Jeremy Hayden, Attorney-in-Fact for Staffan Encrantz 2021-07-19